Protara Therapeutics, Inc.
TARA· Nasdaq
TARAProtara Therapeutics, Inc.
Filed Aug 5, 2021 · 10-Q · 36 days after period end · 0001213900-21-040535
| Metric | Q2 2021 | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|---|
| Net Income | -$12.78M | -$7.14M | -$5.32M | -$4.88M |
| EPS Diluted | -$1.14 | -$1.22 | -$0.56 | -$0.28 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protara Therapeutics, Inc. · CIK 1359931 · Engraved from SEC EDGAR
ended Jun 30, 2021 · filed Aug 5, 2021 · 36 d after period end
